Synthetic Peptide From the V3 Loop Consensus Motif With A Potent Anti-HIV Activity Inhibits Ristocetin-Mediated vWF-GPIb Interaction

[1]  M. Baiocchi,et al.  Human immunodeficiency virus (HIV)-resistant CD4+ UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection. , 1997, Blood.

[2]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[3]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[4]  G Vassart,et al.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.

[5]  H. Mohri,et al.  Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  M. Hoylaerts,et al.  Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin. , 1995, The Biochemical journal.

[7]  P. de Micco,et al.  Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages , 1994, Journal of virology.

[8]  T. Geiser,et al.  Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. , 1994, The Journal of biological chemistry.

[9]  R. Arlinghaus,et al.  Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120 , 1993, Journal of virology.

[10]  J. Ware,et al.  A Role for von Willebrand Factor Proline Residues 702-704 in Ristocetin-Mediated Binding to Platelet Glycoprotein Ib , 1993, Thrombosis and Haemostasis.

[11]  D. Bolognesi.  Human immunodeficiency virus vaccines. , 1993, Advances in virus research.

[12]  C. Ward,et al.  Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. , 1992, Biochemistry.

[13]  H. Gralnick,et al.  A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected]. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Ware,et al.  Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. , 1991, The Journal of biological chemistry.

[15]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[16]  J. Scott,et al.  Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. , 1991, The Journal of biological chemistry.

[17]  C. Cheng‐Mayer,et al.  Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene , 1991, Nature.

[18]  J. Davide,et al.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.

[19]  R. Houghten,et al.  Structure of the von Willebrand factor domain interacting with glycoprotein Ib. , 1988, The Journal of biological chemistry.

[20]  R. Houghten,et al.  Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746. , 1988, The Journal of biological chemistry.

[21]  K. Titani,et al.  A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. , 1987, The Journal of biological chemistry.

[22]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[23]  H. Mohri.  Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia , 1986, American journal of hematology.

[24]  K. Titani,et al.  von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. , 1986, The Journal of biological chemistry.

[25]  C. Jenkin,et al.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.

[26]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.